Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole Effect on Myocardial Contractility in Heart Failure
NCT00699361Phase 3Withdrawn
- Sponsor
- Universitätsklinikum Frankfurt
- Start
- Aug 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pantoprazole in gastroesophageal reflux disease (GERD), sponsored by Universitätsklinikum Frankfurt. Primary endpoint: Influence on myocardial contraction. Planned start Aug 2008; status: withdrawn.
02
Drugs
pantoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00699361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00699361.